Skip to main content
PMC home page
Frontiers in Microbiology logoLink to Frontiers in Microbiology
. 2017 Apr 25;8:713. doi: 10.3389/fmicb.2017.00713

Trans-Cinnamaldehyde, Carvacrol, and Eugenol Reduce Campylobacter jejuni Colonization Factors and Expression of Virulence Genes in Vitro

Abhinav Upadhyay 1, Komala Arsi 1, Basanta R Wagle 1, Indu Upadhyaya 1, Sandip Shrestha 1, Ann M Donoghue 2,†, Dan J Donoghue 1,*
PMCID: PMC5403884  PMID: 28487683

Abstract

Campylobacter jejuni is a major foodborne pathogen that causes severe gastroenteritis in humans characterized by fever, diarrhea, and abdominal cramps. In the human gut, Campylobacter adheres and invades the intestinal epithelium followed by cytolethal distending toxin mediated cell death, and enteritis. Reducing the attachment and invasion of Campylobacter to intestinal epithelium and expression of its virulence factors such as motility and cytolethal distending toxin (CDT) production could potentially reduce infection in humans. This study investigated the efficacy of sub-inhibitory concentrations (SICs, concentration not inhibiting bacterial growth) of three GRAS (generally recognized as safe) status phytochemicals namely trans-cinnamaldehyde (TC; 0.005, 0.01%), carvacrol (CR; 0.001, 0.002%), and eugenol (EG; 0.005, 0.01%) in reducing the attachment, invasion, and translocation of C. jejuni on human intestinal epithelial cells (Caco-2). Additionally, the effect of these phytochemicals on Campylobacter motility and CDT production was studied using standard bioassays and gene expression analysis. All experiments had duplicate samples and were replicated three times on three strains (wild type S-8, NCTC 11168, 81–176) of C. jejuni. Data were analyzed using ANOVA with GraphPad ver. 6. Differences between the means were considered significantly different at P < 0.05. The majority of phytochemical treatments reduced C. jejuni adhesion, invasion, and translocation of Caco-2 cells (P < 0.05). In addition, the phytochemicals reduced pathogen motility and production of CDT in S-8 and NCTC 11168 (P < 0.05). Real-time quantitative PCR revealed that phytochemicals reduced the transcription of select C. jejuni genes critical for infection in humans (P < 0.05). Results suggest that TC, CR, and EG could potentially be used to control C. jejuni infection in humans.

Keywords: Campylobacter jejuni, virulence, attachment, invasion, CDT toxin, phytochemicals, gene expression

Introduction

The foodborne pathogen Campylobacter is the leading cause of bacterial gastroenteritis in humans resulting in an estimated 96 million annual infections globally (Kirk et al., 2015). In the United States, an estimated 1.3 million cases of Campylobacteriosis occur each year largely due to consumption of contaminated poultry products (Newell et al., 2010; CDC, 2014). Chickens act as the reservoir host of Campylobacter, wherein the pathogen colonizes the intestine and can persist for the entire lifespan of the birds without causing any disease. This leads to contamination of carcass during slaughter and increases the risk of human foodborne infections (Allen et al., 2007). After gaining entry through contaminated food in humans, C. jejuni attaches and invades the epithelial layer of lower intestinal tract (ileum, jejunum, colon) followed by epithelial cytopathy and enteritis (Dasti et al., 2010). In most cases, the infection consists of fever, headache, abdominal pain, vomiting, and diarrhea. However, in a minority of individuals, Campylobacteriosis triggers more serious illnesses such as Guillian-Barre Syndrome and Miller-Fisher syndrome that could lead to inflammatory polyneuropathy and fatal paralysis (EFSA, 2011; Silva et al., 2011). A plethora of virulence factors critical for attachment and invasion of epithelial cells, subsequent cytoplasmic proliferation, and cytopathy have been characterized for C. jejuni (Bolton, 2015). Major factors include motility systems (Young et al., 2007), attachment and invasion proteins (CadF, JlpA), and CDT production that causes cellular distension and cell death leading to enteritis (Silva et al., 2011). Thus, reducing the attachment and invasion of C. jejuni on intestinal epithelial cells and production of virulence factors such as motility and CDT could potentially control Campylobacteriosis in humans. Antibiotics such as macrolides (erythromycin, clarithromycin), and fluoroquinolones (ciprofloxacin, levofloxacin, moxifloxacin) are commonly used for treating Campylobacter infections in humans (Blaser and Engberg, 2008); however, there have been reports of development of resistance to these drugs (Engberg et al., 2001; Payot et al., 2006; Luangtongkum et al., 2009; Cha et al., 2016; Olkkola et al., 2016) and several resistance genes have been discovered in Campylobacter spp. (Gibreel et al., 2005; Gibreel and Taylor, 2006; Olkkola et al., 2016). This increase in antibiotic resistance along with reports of adverse drug reactions in patients (Periti et al., 1993; Thong and Tan, 2011) has fueled research exploring the potential of various antibiotic alternatives to combat Campylobacter infections in humans.

Since ancient times, plant extracts have been widely used as food preservatives, flavor enhancers, and dietary supplements for preventing food spoilage and improving human health. In addition, plant extracts are used in herbal medicine for treating various diseases. The antibacterial activity of several phytochemicals has been documented (Burt, 2004; Holley and Patel, 2005). A majority of these compounds are secondary metabolites produced during interaction between plants, animals, and microbes (Reichling, 2010). Trans-cinnamaldehyde (TC) is an aldehyde obtained from bark of cinnamon tree (Cinnamomum zeylandicum). Carvacrol (CR) or cymophenol is the principal antimicrobial ingredient in oregano oil (Origanum vulgare). Eugenol (EG) is yet another polyphenol compound that is the major antimicrobial component present in the oil of cloves (Syzgium aromaticum). All the aforementioned phytochemicals are classified as GRAS (Generally Recognized as Safe) by the FDA, and are approved for addition in food products (Food and Drug Administration, 2012, 2013).

Considerable literature exists on the antibacterial properties of phytochemicals that target cellular viability of bacteria; however, limited information is available on their effect in modulating the various aspects of bacterial virulence critical for causing disease in humans. The present study investigated the efficacy of sub-inhibitory concentrations (SICs, concentrations of compounds not inhibitory to bacterial growth) of TC, CR, and EG in reducing C. jejuni attachment, invasion, and translocation of human intestinal epithelial cells (Caco-2), and production of virulence factors in vitro. In addition, the effect of phytochemicals on the expression of critical virulence genes was investigated using real-time quantitative PCR.

Materials and methods

Campylobacter strains and culture conditions

All culture media were purchased from Difco (Becton Dickinson, Sparks, MD). Three strains of C. jejuni, including wild type S-8 (isolated from commercial broilers raised at University of Arkansas), NCTC 11168, and 81–176 (ATCC BAA-2151) were used in the study. Each strain was cultured separately in 10 ml of sterile Campylobacter Enrichment broth (CEB, Neogen, Lansing, MI) and incubated at 37°C for 48 h in a microaerophilic atmosphere (5% O2, 10% CO2, and 85% N2).

Phytochemicals and determination of sub-inhibitory concentration (SIC)

The SIC of each phytochemical was determined using a previously published protocol (Amalaradjou et al., 2011) with slight modifications. Sterile 96-well polystyrene plates (Costar, Corning Incorporated, Corning, NY) containing serial dilutions of phytochemicals (Sigma-Aldrich) in CEB (100 μl/well) were inoculated with ~5.0 log CFU of C. jejuni in equal volume of CEB, followed by incubation at 37°C for 24 h. Bacterial growth was determined by culturing on Campylobacter Line Agar (CLA) plates (Line, 2001). The highest concentration of phytochemicals that did not inhibit the growth of C. jejuni after 24 h of incubation was selected as its respective SIC for the study. Since 100% ethanol was used as a diluent to increase solubility of phytochemicals for the experiments, its effect (at 0.1% concentration) on the various virulence attributes was also studied.

Bacterial motility assay

The effect of TC, CR, and EG on C. jejuni motility was determined as described previously (Niu and Gilbert, 2004) with modifications. Separate petri dishes containing 25 ml of motility test medium (0.4% agar) with the respective SICs of each phytochemical were prepared. A mid-log culture (8 h) of C. jejuni was centrifuged at 3,600 g for 15 min and washed two times with Butterfield's phosphate diluent (BPD). Five microliters of washed culture (~7 log CFU/ml) was stab inoculated at the center of the motility medium, incubated in microaerophilic environment at 37°C for 24 h, and the zone of motility (bacterial migration distance from the site of stab) was measured.

Cell culture

Human intestinal epithelial cells (Caco-2, ATCC HTB-37) were cultured in 25-cm2 tissue culture flasks (Falcon, Becton and Dickinson Company, Franklin Lakes, NJ) with minimum essential medium (DMEM, Gibco, Invitrogen, Carlsbad, CA) containing 10% (v/v) fetal bovine serum (Invitrogen). The cells were incubated at 37°C in a 5% (v/v) CO2 atmosphere.

Attachment and invasion assay

The effect of SIC of phytochemicals (TC, CR, EG) on C. jejuni adhesion to and invasion of human epithelial cells was determined as previously reported (Koo et al., 2012). Monolayers of Caco-2 cells were grown in 24-well tissue culture plates (Costar) at ~105 cells per well and inoculated with a mid-log culture (8 h) of C. jejuni ~6 log CFU/well (multiplicity of infection-10:1) either alone (control) or in combination with SIC of phytochemicals. The inoculated monolayers were incubated at 37°C for 1.5 h in a microaerophilic environment. For the adhesion assay, the inoculated monolayers (after 1.5 h of incubation) were rinsed three times in BPD and lysed with 1 ml of 0.1% Triton X-100 (Invitrogen, Carlsbad, CA). The number of adherent C. jejuni was determined by serial dilution and plating on CLA plates. For the invasion assay, the Caco-2 monolayer after 1.5 h of incubation (post-inoculation) was rinsed three times in minimal media and incubated for another 2 h in cell culture media containing gentamicin (100 μg/ml) to kill extracellular bacteria. Subsequently, the monolayer was treated with 0.1% triton X-100 as described above. The number of C. jejuni that invaded the epithelial cells was enumerated by serially diluting and plating the cell lysate on CLA plates followed by incubation at 37°C for 48 h for bacterial enumeration.

Epithelial translocation assay

Bacterial epithelial translocation assay was performed as described previously (Koo et al., 2012). Caco-2 cells were cultured on transwell filter inserts (5-μm pore filter, Corning) placed in sterile 24-well tissue culture plates for 10–12 days to form a monolayer. Two hundred microliters of mid-log culture (8 h) of C. jejuni (6 log CFU/ml) inoculum was added to the apical well of the insert and incubated at 37°C for 3 h in a microaerophilic environment. Culture media (600 μl) from the basal well was plated on CLA agar for enumerating the number of C. jejuni that crossed the epithelial barrier.

Cell viability assay for cytolethal distending toxin quantification

CDT activity in the supernatant of C. jejuni culture grown either alone (control) or in the presence of SICs of phytochemicals was quantified by cell viability assay (AbuOun et al., 2005; Lin et al., 2011) with modifications. Briefly, 1 ml of the 48 h culture of C. jejuni (grown with or without phytochemicals) was centrifuged at 10,000 g and the supernatant was collected. Serial 2-fold dilutions (100, 50, 25, 12.5, 6.25, 3.125, 1.56%) of the supernatant were made by mixing 100 μl of supernatant with 100 μl of cell culture medium and were added to Caco-2 cells followed by incubation for 9 days at 37°C. Negative control (0% cytotoxicity, obtained by addition of 200 μl of cell culture medium), media control (obtained by addition of appropriate volumes of CEB), and positive control (100% cytotoxicity, obtained by exposing the Caco-2 cells to cell lysis reagent) were also included for comparison. After 9 days, the amount of LDH release (indicator of cell cytotoxicity) was quantified using CytoTox-ONE homogeneous membrane integrity kit according to the manufacturer's instruction (Promega Inc., Madison, WI). Fluorescence was recorded (excitation wavelength of 560 nm and emission wavelength of 590 nm) on a Synergy 2 plate reader (BioTek, Higland Park, Winooski, VT) and percentage cytotoxicity was calculated according to the formula [Percent cytotoxicity = 100 × (LDHT/LDHC) where LDHT refer to the difference in fluorescence between the sample and negative control (background fluorescence from media], and LDHC refers to the difference in fluorescence between the positive control and negative control respectively.

Real-time quantitative PCR (RT-qPCR)

The effect of phytochemicals on the expression of C. jejuni virulence genes was investigated using real-time quantitative PCR, as described previously (Upadhyay et al., 2012). Each C. jejuni strain was cultured separately with the higher SIC of phytochemicals at 37°C in CEB to mid-log phase (8 h) and total RNA was extracted using RNeasy RNA isolation kit (Qiagen, Valencia, CA). Complementary DNA was synthesized using the Superscript Reverse transcriptase kit (Invitrogen). The cDNA synthesized was used as the template for RT-qPCR. The primers for each gene (Table 1) were designed from published GenBank C. jejuni sequence using NCBI Primer design software. The amplification specificity was tested using NCBI-Primer BLAST, melt curve analysis and in silico PCR amplification (Bikandi et al., 2004). The amplified product was detected using SYBR Green reagent. Relative gene expression was determined using the comparative critical threshold (Ct) method on a Quant Studio 3 Real Time PCR system. Data were normalized to the endogenous control (16S rRNA gene), and the level of candidate gene expression between control and phytochemical treated sample was analyzed.

Table 1.

List of primers used for real-time qPCR analysis.

Gene with accession number Primer Sequence (5′–3′)
16S-rRNA (NC_002163.1) Forward 5′-TGAGGGAGAGGCAGATGGAA-3′
Endogenous control (Product length 78) Reverse 5′-TCGCCTTCGCAATGGGTATT-3′
motA (NC_002163.1) Forward 5′-AGCGGGTATTTCAGGTGCTT-3′
Flagellar motor protein A (Product length 75 bp) Reverse 5′-CCCCAAGGAGCAAAAAGTGC-3′
motB (NC_002163.1) Forward 5′-AATGCCCAGAATGTCCAGCA-3′
Flagellar motor protein A (Product length 51 bp) Reverse 5′-AGTCTGCATAAGGCACAGCC -3′
fliA (NC_002163.1) Forward 5′-AGCTTTCACGCCGTTACGAT-3′
Flagellar sigma factor (Product length 56 bp) Reverse 5′-TCTTGCAAAACCCCAGAAGT-3′
cadF (NC_002163.1) Forward 5′-CGCGGGTGTAAAATTCCGTC-3′
Campylobacter adhesion to fibronectin (Product length 135 bp) Reverse 5′-TCCTTTTTGCCACCAAAACCA-3′
ciaB (NC_002163.1) Forward 5′-TCTCAGCTCAAGTCGTTCCA -3′
Campylobacter invasion antigen B (Product length 50 bp) Reverse 5′-GCCCGCCTTAGAACTTACAA -3′
jlpA (NC_002163.1) Forward 5′-AGCACACAGGGAATCGACAG -3′
Jejuni lipoprotein A (Product length 66 bp) Reverse 5′-TAACGCTTCTGTGGCGTCTT -3′
cdtA (NC_002163.1) Forward 5′-TTTTGAAAATCGCCCTGCGG-3′
Cytolethal distending toxin A (Product length 57 bp) Reverse 5′-GCTCCGCTAGGGCCTAAAAT-3′
cdtB (NC_002163.1) Forward 5′-CTAGCGCAACTCAAGCAAGC-3′
Cytolethal distending toxin B (Product length 98 bp) Reverse 5′-AATCGCAGCTAAAAGCGGTG-3′
cdtC (NC_002163.1) Forward 5′-TAGCCCCTTGCACCCTAGAT-3′
Cytolethal distending toxin C (Product length 80 bp) Reverse 5′-AGCAGCTGTTAAAGGTGGGG-3′
cetA (NC_002163.1) Forward 5′-CCTACCATGCTCTCCTGCAC -3′
Campylobacter energy taxis protein (Product length 78 bp) Reverse 5′-CGCGATATAGCCGATCAAACC-3′
cetB (NC_002163.1) Forward 5′-GCCTTGTTGCTGTTCTGCTC -3′
Campylobacter energy taxis protein (Product length 88 bp) Reverse 5′-TTCCGTTCGTCGTATGCCAA -3′
racS (NC_002163.1) Forward 5′-AGACAAGTTGCCGAAGTTGC -3′
Reduced ability to colonize system Sensor (Product length 79 bp) Reverse 5′-AGGCGATCTTGCCTACTTCA -3′
racR (NC_002163.1) Forward 5′-AGAGAACAGCTTGTAAGTCGCT-3′
Reduced ability to colonize system Response regulator (Product length 83 bp) Reverse 5′-ACCCTTAAGCGACCGATGAT -3′
Open in a new tab

Statistical analysis

A completely randomized designed was used for the study. The bacterial counts were logarithmically transformed before analysis to achieve homogeneity of variance (Byrd et al., 2001). All experiments had duplicate samples and were replicated three times on three strains (wild type S-8, NCTC 11168, 81–176) of C. jejuni. Data from independent trials were pooled and analyzed using ANOVA with Fisher LSD test for multiple comparisons on GraphPad Prism ver 6.0. Differences were considered significant with P-values < 0.05.

Results

The two SICs of phytochemicals that did not reduce C. jejuni (S-8, NCTC 11168, 81–176) growth as compared to respective control were 0.005, 0.01% for TC and EG, and 0.001, 0.002% for CR (data not shown). The SICs of phytochemicals did not change the pH of the culture media (P > 0.05).

Effect of phytochemicals on C. jejuni motility

The effect of TC, CR, and EG on C. jejuni S-8 motility is presented in Figure 1A. All three phytochemicals at their respective SICs reduced C. jejuni S-8 motility (P < 0.05). TC was found to be the most effective treatment and decreased C. jejuni S-8 motility by >70% resulting in less than 1.0 cm zone as compared to control (5 cm) after 24 h incubation. Similar results were obtained with C. jejuni NCTC 11168 (Figure 1B) and C. jejuni 81–176 (Figure 1C) where all the phytochemical treatments significantly reduced pathogen motility.

Figure 1.

Figure 1

Open in a new tab

Effect of phytochemicals on Campylobacter jejuni (A) S-8 (B) NCTC 11168 (C) 81–176 motility. The treatments include control, ethanol, TC (0.005, 0.01%), CR (0.001, 0.002%), and EG (0.005, 0.01%). Error bars represent SEM (n = 6). Bars with different letters represent a significant difference between treatments (P < 0.05).

Effect of phytochemicals on C. jejuni attachment, invasion, and translocation of Caco-2 cells

Tissue culture studies showed that the majority of phytochemical treatments decreased attachment, invasion and translocation of C. jejuni on Caco-2 cells in comparison to controls (Figures 2–4). For example, the SICs of TC, CR, and EG decreased attachment of C. jejuni S-8 by ~1–1.5 log CFU/ml as compared to control which had an attachment of ~4.2 log CFU/ml (Figure 2A). All phytochemicals except EG 0.005% reduced C. jejuni S-8 invasion as compared to controls (Figure 3A; P < 0.05). TC 0.01% was the most effective treatment and reduced the number of invading C. jejuni S-8 by ~1.5 log CFU/ml (P < 0.05). For TC and EG treatments, a concentration dependent reduction in C. jejuni S-8 invasion was observed. For translocation assay, all phytochemical treatments were able to significantly reduce C. jejuni S-8 translocation of Caco-2 cells (Figure 4A). The phytochemical treatments also reduced the attachment, invasion, and translocation of C. jejuni NCTC 11168 (Figures 2B,3B,4B) and C. jejuni 81–176 (Figures 2C,3C,4C). In case of C. jejuni NCTC 11168, a reduction of ~0.5–1 log CFU/ml was observed in adhesion to Caco-2 cells when exposed to phytochemicals (Figure 2B). Similarly, all phytochemical treatments reduced the attachment of C. jejuni 81–176 by at least 1 log CFU/ml as compared to control (Figure 2C). In case of invasion assay, both TC treatments, and lower SIC of CR and EG were not effective in reducing C. jejuni NCTC 11168 invasion (P > 0.05). However, the higher SIC of CR and EG reduced the invasion of all three strains of C. jejuni as compared to controls (P < 0.05). EG 0.01% treatment also exerted significant anti-translocation efficacy and completely inhibited the transfer of all three C. jejuni strains across the epithelial barrier (Figure 4; P < 0.05). None of the phytochemical treatments affected the health or integrity of Caco-2 cells (P > 0.05; data not shown).

Figure 2.

Figure 2

Open in a new tab

Effect of phytochemicals on attachment of Campylobacter jejuni (A) S-8 (B) NCTC 11168 (C) 81–176 to Caco-2 cells. The treatments include control, ethanol, TC (0.005, 0.01%), CR (0.001, 0.002%), and EG (0.005, 0.01%). Error bars represent SEM (n = 6). Bars with different letters represent a significant difference between treatments (P < 0.05).

Figure 4.

Figure 4

Open in a new tab

Effect of phytochemicals on Campylobacter jejuni (A) S-8 (B) NCTC 11168 (C) 81–176 translocation of Caco-2 cells. The treatments include control, ethanol, TC (0.005, 0.01%), CR (0.001, 0.002%), and EG (0.005, 0.01%). Error bars represent SEM (n = 6). Bars with different letters represent a significant difference between treatments (P < 0.05).

Figure 3.

Figure 3

Open in a new tab

Effect of phytochemicals on Campylobacter jejuni (A) S-8 (B) NCTC 11168 (C) 81–176 invasion of Caco-2 cells. The treatments include control, ethanol, TC (0.005, 0.01%), CR (0.001, 0.002%), and EG (0.005, 0.01%). Error bars represent SEM (n = 6). Bars with different letters represent a significant difference between treatments (P < 0.05).

Effect of phytochemicals on C. jejuni induced cytotoxicity of Caco-2 cells

All phytochemicals except CR 0.001% reduced C. jejuni S-8 toxin induced cytotoxicity by at least 30% as compared to control (Figure 5A). A concentration dependent reduction in cell cytotoxicity was observed in TC treatments. The lower concentration of TC (0.005%) reduced cell cytotoxicity by ~30%, whereas the higher concentration (0.01%) reduced cell cytotoxicity by ~60% as compared to controls (P < 0.05). In case of C. jejuni NCTC 11168, only CR 0.002% and EG 0.01% were effective in reducing cell cytotoxicity by ~30% (Figure 5B; P < 0.05). None of the phytochemical treatments were able to reduce cell cytotoxicity mediated by C. jejuni 81–176 (Figure 5C; P > 0.05).

Figure 5.

Figure 5

Open in a new tab

Effect of phytochemicals on Campylobacter jejuni (A) S-8 (B) NCTC 11168 (C) 81–176 induced cytotoxicity on Caco-2 cells. The treatments include control, ethanol, TC (0.005, 0.01%), CR (0.001, 0.002%), and EG (0.005, 0.01%). Error bars represent SEM (n = 6). Bars with different letters represent a significant difference between treatments (P < 0.05).

Effect of phytochemicals on expression of C. jejuni virulence genes

Effect of phytochemicals on expression of virulence genes in the three strains of C. jejuni is presented in Table 2. Real-time quantitative PCR results revealed that TC 0.01% down-regulated the expression of virulence genes coding for motility (fliA), attachment (cadF) and toxin production (cdtA, cdtB, cdtC) in C. jejuni S-8. CR and EG did not significantly reduce the expression of the tested virulence genes in C. jejuni S-8 except for racR by EG. Interestingly, many of the virulence genes were upregulated by CR and EG treatments (P < 0.05). The ethanol treatments did not affect the expression of the tested virulence genes in C. jejuni S-8 (P > 0.05). In case of C. jejuni NCTC 11168, CR 0.002%, and EG 0.01% treatments reduced the expression of motA, cadF, cdtB, and motA, cdtA genes respectively (P < 0.05). The expression of the tested genes was not affected by ethanol treatment (P > 0.05). None of the phytochemical treatments were able to significantly reduce the expression of tested genes in C. jejuni 81–176 (P > 0.05). Interestingly, the expression of select genes in C. jejuni NCTC 11168 (motB, jlpA) and C. jejuni 81–176 (motA, motB, cadF, jlpA, cdtA,B,C) was upregulated by 0.01% TC treatment and CR 0.002, EG 0.01% treatments respectively (P < 0.05).

Table 2.

Effect of TC 0.01%, CR 0.002%, EG 0.01%, and ethanol on the expression of Campylobacter jejuni (S-8, NCTC 11168, 71–176) virulence genes.

Gene Relative fold change (Log10RQ)
TC 0.01% CR 0.002%
S-8 11168 81–176 S-8 11168 81–176
motA −0.2 ± 0.2a 0.05 ± 0.4ab 0.6 ± 0.2b −0.2 ± 0.07a −0.7 ± 0.1b* 1.5 ± 0.09c*
motB −0.1 ± 0.1a 0.5 ± 0.02a* 0.5 ± 0.7a −0.009 ± 0.03a −0.2 ± 0.3a 1.7 ± 0.05b*
fliA −0.3 ± 0.2a* 0.3 ± 0.08a 0.1 ± 0.1a −0.06 ± 0.1a 0.08 ± 0.2a 0.08 ± 0.1a
cadF −0.3 ± 0.2a* −0.09 ± 0.1a 0.2 ± 0.6a −0.2 ± 0.1a −0.6 ± 0.2a* 1.2 ± 0.03b*
ciaB 0.07 ± 0.04a 0.2 ± 0.06a 0.3 ± 0.07a −0.1 ± 0.06a 0.1 ± 0.2a 0.2 ± 0.2a
jlpA −0.09 ± 0.08a 0.6 ± 0.1a* 0.6 ± 0.3a −0.06 ± 0.04a −0.1 ± 0.1a* 1.7 ± 0.2b*
cdtA −0.4 ± 0.1a* 0.3 ± 0.07ab 0.5 ± 0.3b −0.1 ± 0.06a −0.3 ± 0.1a 1.7 ± 0.06b*
cdtB −0.5 ± 0.19a* 0.08 ± 0.1ab 0.6 ± 0.2b −0.2 ± 0.04a −0.4 ± 0.1a* 1.9 ± 0.1b*
cdtC −0.4 ± 0.17a* 0.0004 ± 0.2ab 0.5 ± 0.3b −0.09 ± 0.1a −0.1 ± 0.1a 1.8 ± 0.2b*
cetA −0.05 ± 0.04a 0.1 ± 0.1a 0.2 ± 0.1a 0.3 ± 0.11a* 0.05 ± 0.05a 0.2 ± 0.2a
cetB −0.08 ± 0.04a 0.3 ± 0.07a 0.06 ± 0.1a 0.2 ± 0.007a 0.29 ± 0.07a 0.3 ± 0.07a
racS −0.2 ± 0.07a 0.19 ± 0.06a 0.1 ± 0.1a 0.4 ± 0.04a* 0.3 ± 0.07a 0.3 ± 0.1a
racR −0.1 ± 0.07a 0.18 ± 0.1a 0.1 ± 0.2a 0.2 ± 0.05a 0.03 ± 0.1a 0.2 ± 0.03a
Gene EG 0.01% Ethanol
motA 0.2 ± 0.09a −0.7 ± 0.06b* 1.2 ± 0.1c* 0.04 ± 0.05a 0.03 ± 0.1a 0.06 ± 0.1a
motB 0.4 ± 0.07a* −0.4 ± 0.2b 1.4 ± 0.2c* −0.02 ± 0.2a 0.3 ± 0.1a 0.1 ± 0.1a
fliA 0.2 ± 0.07a 0.08 ± 0.05a 0.2 ± 0.1a −0.03 ± 0.1a 0.4 ± 0.08b 0.08 ± 0.1ab
cadF 0.3 ± 0.1a* 0.12 ± 0.1a 0.9 ± 0.1b* 0.08 ± 0.06a −0.1 ± 0.01a −0.1 ± 0.3a
ciaB 0.2 ± 0.08a 0.4 ± 0.1a 0.5 ± 0.2a 0.03 ± 0.04a 0.3 ± 0.01a 0.1 ± 0.09a
jlpA 0.3 ± 0.1a* −0.2 ± 0.2a 1.4 ± 0.1a* 0.03 ± 0.04a 0.15 ± 0.1a −0.04 ± 0.1a
cdtA 0.3 ± 0.08a* −0.4 ± 0.08b* 1.3 ± 0.1c* 0.1 ± 0.03a 0.16 ± 0.08a −0.04 ± 0.1a
cdtB 0.03 ± 0.07a 0.01 ± 0.09a 1.4 ± 0.1b* 0.06 ± 0.02a 0.1 ± 0.1a 0.1 ± 0.1a
cdtC 0.1 ± 0.1a 0.1 ± 0.1a 1.08 ± 0.1b* −0.17 ± 0.1a −0.1 ± 0.1a 0.03 ± 0.1a
cetA 0.3 ± 0.03a* 0.08 ± 0.06a 0.2 ± 0.07a −0.02 ± 0.2a 0.09 ± 0.08a 0.1 ± 0.04a
cetB 0.3 ± 0.1a* 0.11 ± 0.1a 0.4 ± 0.05a 0.08 ± 0.06a −0.03 ± 0.09a −0.1 ± 0.1a
racS −0.1 ± 0.14a 0.32 ± 0.1b −0.1 ± 0.1a 0.16 ± 0.03a −0.01 ± 0.1a 0.3 ± 0.1a
racR −0.3 ± 0.01a* 0.06 ± 0.04b 0.2 ± 0.02b 0.03 ± 0.04a −0.3 ± 0.2a −0.07 ± 0.1a
Open in a new tab

Values represent Mean ± SEM. Control had a basal RQ of 1 (log10 RQ = 0).

*

Relative fold change significantly different from control. Superscripts with different letters in a row represent significant difference between C. jejuni strains for a treatment.

Discussion

The colonization of enteric pathogens in the gut and their interaction with the human intestinal cells is central to most infections and illnesses. The poultry associated foodborne pathogen C. jejuni expresses an array of virulence factors that orchestrate its pathophysiology in humans. In this study we investigated the effect of phytochemicals trans-cinnamaldehyde, carvacrol, and eugenol in reducing the expression of virulence factors of C. jejuni in vitro as a first step before conducting future in vivo studies.

The motility imparted by the polar flagella of C. jejuni is essential for colonization of the mucus lining of the intestinal tract and subsequent attachment and invasion of intestinal epithelium (Guerry, 2007). Our results revealed that TC, CR, and EG significantly decreased C. jejuni motility (Figures 1A–C). In addition, majority of phytochemical treatments at their higher SIC also reduced attachment, invasion and translocation of C. jejuni through intestinal epithelial cells (Figures 2–4). (van Alphen et al., 2012) had similar findings and observed that pre-exposure of C. jejuni to low concentrations of carvacrol modulated motility and invasion of INT-407 intestinal epithelial cells without affecting intracellular ATP levels or epithelial function. Reduced motility and attachment efficiency in C. jejuni on exposure to clove oil (Kovács, 2014), thyme (Pogacar et al., 2016), herbal extracts (Bensch et al., 2011), and campynexins (Johnson et al., 2015) have also been observed.

After invading the human intestinal epithelium, C. jejuni produces the tripartite CDT toxin. The catalytic domain (CdtB) localizes in the nucleus leading to DNA damage, cell-cycle arrest, and cytotoxicity (Pickett et al., 1996; Lara-Tejero and Galán, 2000; Young et al., 2007). The activity of CDT was first described in culture supernatants that caused eukaryotic cells to slowly distend over a period of 2–5 days, eventually leading to cell death (Johnson and Lior, 1988). We observed that majority of phytochemical treatments significantly reduced the C. jejuni S-8 CDT mediated cell cytotoxicity in Caco-2 cells (Figure 5A). Previously, Castillo et al. (2011) demonstrated that extracts from A. farnesiana and A. ludoviciana inhibited cytotoxin production in C. jejuni and C. coli. In another study, Gillespie et al. (2013) screened 30,000 small molecules for toxin inhibition activity and observed that 4-bromobenzaldehyde N-(2, 6-dimethyphenyl) semicarbazone (EGA) inhibited intoxication by CDT derived from Haemophilus ducreyi and Escherichia coli. Although the phytochemical treatments were found to be effective against C. jejuni S-8 mediated cell cytotoxicity, considerable strain based variation in their efficacy was observed in our assay (Figures 5B,C). We believe that this result is due to variations in the genomic composition of the three strains tested that could potentially alter the molecular targets of phytochemicals. For example, Jeon et al. (2005) reported that a mutation in luxS gene (coding for quorum sensing) affected the transcription of CDT operon. Since phytochemicals are known to exert their effect by modulating luxS and quorum sensing (Koh and Tham, 2011; Nazzaro et al., 2013; Upadhyay et al., 2013), a disruption of their efficacy due to changes in target genes coding for quorum sensing is possible.

It has been previously shown that sub-inhibitory or sub-lethal concentrations of antimicrobials modulate the transcription of genes in various bacterial pathogens (Fonseca et al., 2004; Tsui et al., 2004; Upadhyay et al., 2012) including C. jejuni (Arambel et al., 2015; Oh and Jeon, 2015). Since the sub-inhibitory concentrations of phytochemicals did not inhibit the growth of C. jejuni, the reduction observed in C. jejuni virulence attributes could be due to the effect of phytochemicals on the transcription of virulence genes. Therefore, we used RT-qPCR to determine the effect of phytochemicals on the expression of genes, which have been previously reported to contribute to the C. jejuni infection process in humans. We selected an incubation time of 8 h since we wanted to investigate the effect of phytochemicals on the expression of virulence genes of C. jejuni over extended exposure time, as would be the case in the human gut. 16S rRNA gene was selected as endogenous control since it was stable in its expression between control and treatment groups. Several other researchers have also used 16S rRNA gene as endogenous control for studying the expression of virulence genes in pathogens (McKillip et al., 1998; Tasara and Stephan, 2007; Xue et al., 2008; Hays, 2009; Atshan et al., 2013; Schroeder et al., 2015) including C. jejuni (Koolman et al., 2016). The flagellar biosynthesis gene, fliA regulates several genes involved in Campylobacter motility. Genes motA and motB code for flagella motor function and aid in motility and colonization (Hermans et al., 2011). cetA and cetB are energy taxis genes that contribute to directional motility of Campylobacter in response to changes in external environment. The Campylobacter surface protein CadF in combination with CiaB (Young et al., 2007) and JlpA mediates binding of the pathogen to host epithelial cells through fibronectin-mediated attachment thereby facilitating colonization (Konkel et al., 1999, 2005; Monteville and Konkel, 2002; Monteville et al., 2003). RacS-RacR is another important two-component regulatory system that plays a role in temperature dependent growth and colonization in C. jejuni (Brás et al., 1999). In addition to the aforementioned attachment and motility factors, C. jejuni produces CDT encoded by cdtA, cdtB, and cdtC genes. The subunits CdtA and CdtC associate with the nuclease CdtB to form a tripartite complex that translocate CdtB into the host cell leading to arrest in cell cycle, cell death and enteritis (Young et al., 2007). We observed that phytochemicals modulated the expression of some of the virulence genes tested and this varied among the three strains of C. jejuni. For example, SIC of TC decreased the expression of genes coding for motility (fliA) and attachment (cadF) in strain S-8 (Table 2). In addition, TC down-regulated the transcription of cdtA, cdtB, and cdtC genes that contribute to CDT-mediated cell lysis in C. jejuni S-8. Thus, the reduced cell cytotoxicity observed in response to TC (Figure 5A) could potentially be due to the effect of TC on the expression of related genes in C. jejuni S-8. We did not observe significant down-regulation in the expression of cdtA,B,C genes in response to TC in C. jejuni NCTC 11168 and C. jejuni 81–176 (Table 2). This was reflected in the phenotypic assay as well where TC did not significantly reduce cell cytotoxicity in the two strains (Figures 5B,C). Similarly, CR down-regulated the expression of genes critical for motility (motA), attachment (cadF), and CDT production (cdtB) in C. jejuni NCTC 11168, whereas it did not reduce the expression of tested genes in wild type S-8 or 81–176 (Table 2). A directly related finding to this gene expression result was observed in the cell cytotoxicity assay where only higher SIC of CR reduced C. jejuni NCTC 11168 mediated cell cytoxicity (Figure 5B) whereas none of the CR treatments reduced C. jejuni 81–176 mediated cell cytotoxicity of Caco-2 cells (Figure 5C). As observed with TC and CR, EG also affected the expression of genes in the three strains differently. EG 0.01% treatment significantly reduced the expression of racR in C. jejuni S-8 and motA, cdtA genes in C. jejuni NCTC 11168 (Table 2), whereas the expression of genes in C. jejuni 81–176 was not reduced. These results indicate that phytochemicals exert their anti-virulence effect via only selected genes and this could vary among different strains of the pathogen. Previously, Lee et al. (2012) showed that flavones could exert anti-virulence effect by modulating only selected genes (sae and agr) in Staphylococcus aureus. Expression of genes such as sigB (RNA polymerase sigma factor) and sar (accessory regulator A) was not affected by flavones. In a recent study, Singh et al. (2016) reported that eugenol has strong binding affinity for surface exposed lysines in proteins. The essential oil inhibited formation of glycation end products by binding to ε-amine group on lysine. In another study, carvacrol was found to inhibit the binding of nicotine to nicotinic acetylcholine receptor (Tong et al., 2013) indicating that these phytochemicals could be exerting their anti-virulence properties through modulating receptor binding of virulence proteins in C. jejuni in addition to their effect on gene expression. Moreover, carvacrol has been shown to modulate the expression of HSP60 (GroEL) chaperones and other proteins that affect protein folding in Escherichia coli O157:H7 (Burt et al., 2007) and Listeria monocytogenes (Guevara et al., 2015). Therefore, it is possible that phytochemicals may be exerting their anti-virulence effect against C. jejuni via similar mechanism(s) that affect protein folding.

In conclusion, our study showed that phytochemicals TC, CR, and EG were effective in reducing the virulence attributes of C. jejuni critical for causing infection in humans. Since phytochemicals including TC, CR, and EG have been found to be stable in the gastrointestinal tract of monogastric animals (Si et al., 2006; Michiels et al., 2008), these plant compounds could potentially be used as dietary supplements to control C. jejuni infection in humans. However, in vivo studies in an appropriate mammalian model along with genomic characterization, transcriptomic and proteomic profiling of pathogens are necessary to validate the antimicrobial efficacy, mechanism of action, and safety of the plant compounds.

Author contributions

AU designed the study. AU, KA, BW, IU, and SS conducted the experiments. AU analyzed the data and wrote the manuscript. AD and DD critically analyzed and revised the manuscript.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. AbuOun M., Manning G., Cawthraw S. A., Ridley A., Ahmed I. H., Wassenaar T. M., et al. (2005). Cytolethal distending toxin (CDT)-negative Campylobacter jejuni strains and Anti-CDT neutralizing antibodies are induced during human infection but not during colonization in chickens. Infect. Immun. 73, 3053–3062. 10.1128/IAI.73.5.3053-3062.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Allen V. M., Bull S. A., Corry J. E., Domingue G., Jørgensen F., Frost J. A., et al. (2007). Campylobacter spp. contamination of chicken carcasses during processing in relation to flock colonisation. Int. J. Food Microbiol. 13, 54–61. 10.1016/j.ijfoodmicro.2006.07.011 [DOI] [PubMed] [Google Scholar]
  3. Amalaradjou M. A., Narayanan A., Venkitanarayanan K. (2011). Trans-cinnamaldehyde decreases attachment and invasion of uropathogenic Escherichia coli in urinary tract epithelial cells by modulating virulence gene expression. J. Urol. 185, 1526–1531. 10.1016/j.juro.2010.11.078 [DOI] [PubMed] [Google Scholar]
  4. Arambel H. R., Donoghue A. N., Arsi K., Upadhyay A., Woo-Ming A., Blore P., et al. (2015). Chitosan supplementation reduces enteric colonization of Campylobacter jejuni in broiler chickens and down-regulates expression of colonization genes. Adv. Food Tech. Nutr. Sci. 1, 104–111. 10.17140/AFTNSOJ-1-119 [DOI] [Google Scholar]
  5. Atshan S. S., Shamsudin M. N., Karunanidhi A., van Belkum A., Lung L. T., Sekawi Z., et al. (2013). Quantitative PCR analysis of genes expressed during biofilm development of methicillin resistant Staphylococcus aureus (MRSA). Infect. Genet. Evol. 18, 106–112. 10.1016/j.meegid.2013.05.002 [DOI] [PubMed] [Google Scholar]
  6. Bensch K., Tiralongo J., Schmidt K., Matthias A., Bone K. M., Lehmann R., et al. (2011). Investigations into the antiadhesive activity of herbal extracts against Campylobacter jejuni. Phytother. Res. 25, 1125–1132. 10.1002/ptr.3384 [DOI] [PubMed] [Google Scholar]
  7. Bikandi J., San Millán R., Rementeria A., Garaizar J. (2004). In silico analysis of complete bacterial genomes: PCR, AFLP–PCR and endonuclease restriction. Bioinformatics 20, 798–799. 10.1093/bioinformatics/btg491 [DOI] [PubMed] [Google Scholar]
  8. Blaser M. J., Engberg J. (2008). Clinical aspects of Campylobacter jejuni and Campylobacter coli infections, in Campylobacter, 3rd Edn, eds Nachamkin I., Szymanski C., Blaser M. (Washington, DC: ASM Press; ), 99–121. [Google Scholar]
  9. Bolton D. J. (2015). Campylobacter virulence and survival factors. Food Microbiol. 48, 99–108. 10.1016/j.fm.2014.11.017 [DOI] [PubMed] [Google Scholar]
  10. Brás A. M., Chatterjee S., Wren B. W., Newell D. G., Ketley J. M. (1999). A novel Campylobacter jejuni two-component regulatory system important for temperature-dependent growth and colonization. J. Bacteriol. 181, 3298–3302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Burt S. (2004). Essential oils: their antibacterial properties and potential applications in foods—a review. Int. J. Food Microbiol. 94, 223–253. 10.1016/j.ijfoodmicro.2004.03.022 [DOI] [PubMed] [Google Scholar]
  12. Burt S. A., van der Zee R., Koets A. P., Graaff A. M., van Knapen F., Gaastra W., et al. (2007). Carvacrol induces heat shock protein 60 and inhibits synthesis of flagellin in Escherichia coli O157:H7. Appl. Environ. Microbiol. 73, 4484–4490. 10.1128/AEM.00340-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Byrd J. A., Hargis B. M., Caldwell D. J., Bailey R. H., Herron K. L., McReynolds J. L., et al. (2001). Effect of lactic acid administration in the drinking water during preslaughter feed withdrawal on Salmonella and Campylobacter contamination of broilers. Poult. Sci. 80, 278–283. 10.1093/ps/80.3.278 [DOI] [PubMed] [Google Scholar]
  14. Castillo S. L., Heredia N., Contreras J. F., García S. (2011). Extracts of edible and medicinal plants in inhibition of growth, adherence, and cytotoxin production of Campylobacter jejuni and Campylobacter coli. J. Food Sci. 76, M421–M426. 10.1111/j.1750-3841.2011.02229.x, [DOI] [PubMed] [Google Scholar]
  15. CDC (2014). Campylobacter. Available online at: https://www.cdc.gov/foodsafety/diseases/campylobacter/
  16. Cha W., Mosci R., Wengert S. L., Singh P., Newton D. W., Salimnia H., et al. (2016). Antimicrobial susceptibility profiles of human Campylobacter jejuni isolates and association with phylogenetic lineages. Front. Microbiol. 7:589. 10.3389/fmicb.2016.00589 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Dasti J. I., Tareen A. M., Lugert R., Zautner A. E., Groß U. (2010). Campylobacter jejuni: a brief overview on pathogenicity-associated factors and disease-mediating mechanisms. Int. J. Med. Microbiol. 300, 205–211. 10.1016/j.ijmm.2009.07.002 [DOI] [PubMed] [Google Scholar]
  18. EFSA (2011). Scientific opinion on Campylobacter in broiler meat production: control options and performance objectives and/or targets at different stages of the food chain. EFSA J. 9, 2105–2246. 10.2903/j.efsa.2011.2105 [DOI] [Google Scholar]
  19. Engberg J., Aarestrup F. M., Taylor D. E., Gerner-Smidt P., Nachamkin I. (2001). Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg. Infect. Dis. 7, 24–34. 10.3201/eid0701.010104 [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Fonseca A. P., Extremina C., Fonseca A. F., Sousa J. C. (2004). Effect of subinhibitory concentration of piperacillin/tazobactam on Pseudomonas aeruginosa. J. Med. Microbiol. 53, 903–910. 10.1099/jmm.0.45637-0 [DOI] [PubMed] [Google Scholar]
  21. Food Drug Administration (2012). Code of Federal Regulations Title 21 Part 172. Available online at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?. CFRPart1/4172.
  22. Food Drug Administration (2013). Everything Added to Food in the United States (EAFUS). Doc. No. 3045-2, 4-Dihydroxybenzoic Acid. Available online at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?
  23. Gibreel A., Kos V. N., Keelan M., Trieber C. A., Levesque S., Michaud S., et al. (2005). Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype. Antimicrob. Agents Chemother. 49, 2753–2759. 10.1128/AAC.49.7.2753-2759.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Gibreel A., Taylor D. E. (2006). Macrolide resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob. Agents Chemother. 58, 243–255. 10.1093/jac/dkl210 [DOI] [PubMed] [Google Scholar]
  25. Gillespie E. J., Ho C. L., Balaji K., Clemens D. L., Deng G., Wang Y. E., et al. (2013). Selective inhibitor of endosomal trafficking pathways exploited by multiple toxins and viruses. Proc. Natl. Acad. Sci. U.S.A. 110, E4904–E4912. 10.1073/pnas.1302334110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Guerry P. (2007). Campylobacter flagella: not just for motility. Trends Microbiol. 15, 456–461. 10.1016/j.tim.2007.09.006 [DOI] [PubMed] [Google Scholar]
  27. Guevara L., Antolinos V., Palop A., Periago P. M. (2015). Impact of moderate heat, carvacrol, and thymol treatments on the viability, injury, and stress response of Listeria monocytogenes. Biomed Res. Int. 2015:548930. 10.1155/2015/548930 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Hays J. P. (2009). The evaluation of putative endogenous control housekeeping genes for real-time polymerase chain reaction expression studies in Moraxella catarrhalis. Diagn. Microbiol. Infect. Dis. 65, 323–326. 10.1016/j.diagmicrobio.2009.06.021 [DOI] [PubMed] [Google Scholar]
  29. Hermans D., Van Deun K., Martel A., Van Immerseel F., Messens W., Heyndrickx M., et al. (2011). Colonization factors of Campylobacter jejuni in the chicken gut. Vet. Res. 42:82. 10.1186/1297-9716-42-82 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Holley R. A., Patel D. (2005). Improvement in shelf-life and safety of perishable foods by plant essential oils and smoke antimicrobials. Food Microbiol. 22, 273–292. 10.1016/j.fm.2004.08.006 [DOI] [Google Scholar]
  31. Jeon, Itoh K., Ryu S. (2005). Promoter analysis of cytolethal distending toxin genes (cdtA, B, and C) and effect of a luxS mutation on CDT production in Campylobacter jejuni. Microbiol. Immunol. 49, 599–603. 10.1111/j.1348-0421.2005.tb03651.x [DOI] [PubMed] [Google Scholar]
  32. Johnson J. G., Yuhas C., McQuade T. J., Larsen M. J., DiRita V. J. (2015). Narrow-spectrum inhibitors of Campylobacter jejuni flagellar expression and growth. Antimicrb. Agents Chemther. 59, 3880–3886. 10.1128/AAC.04926-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Johnson W. M., Lior H. (1988). A new heat-labile cytolethal distending toxin (CLDT) produced by Campylobacter spp. Microb. Path 4, 115–126. 10.1016/0882-4010(88)90053-8 [DOI] [PubMed] [Google Scholar]
  34. Kirk M. D., Pires S. M., Black R. E., Caipo M., Crump J. A., Devleesschauwer B., et al. (2015). World Health Organization estimates of the global and regional disease burden of 22 foodborne bacterial, protozoal, and viral diseases, 2010: a data synthesis. PLoS Med. 12:e1001921. 10.1371/journal.pmed.1001921 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Koh K. H., Tham F. Y. (2011). Screening of traditional Chinese medicinal plants for quorum-sensing inhibitors activity. J. Microbiol. Immunol. Infect. 44, 144–148. 10.1016/j.jmii.2009.10.001 [DOI] [PubMed] [Google Scholar]
  36. Konkel M. E., Christensen J. E., Keech A. M., Monteville M. R., Klena J. D., Garvis S. G. (2005). Identification of a fibronectin-binding domain within the Campylobacter jejuni CadF protein. Mol. Microbiol. 57, 1022–1035. 10.1111/j.1365-2958.2005.04744.x [DOI] [PubMed] [Google Scholar]
  37. Konkel M. E., Kim B. J., Rivera-Amill V., Garvis S. G. (1999). Bacterial secreted proteins are required for the internalization of Campylobacter jejuni into cultured mammalian cells. Mol. Microbiol. 32, 691–701. 10.1046/j.1365-2958.1999.01376.x [DOI] [PubMed] [Google Scholar]
  38. Koo O. K., Amalaradjou M. A., Bhunia A. K. (2012). Recombinant probiotic expressing Listeria adhesion protein attenuates Listeria monocytogenes virulence in vitro. PLoS ONE 7:e29277. 10.1371/journal.pone.0029277 [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Koolman L., Whyte P., Burgess C., Bolton D. (2016). Virulence gene expression, adhesion and invasion of Campylobacter jejuni exposed to oxidative stress (H2O2). Int. J. Food Microbiol. 220, 33–38. 10.1016/j.ijfoodmicro.2016.01.002 [DOI] [PubMed] [Google Scholar]
  40. Kovács J. K. (2014). Investigation of Virulence-Associated Factors in the Pathogenesis of Campylobacter jejuni, and the Anti-Campylobacter Mode of Action of Clove Essential oil. Doctoral dissertation University of Pécs, Hungary.
  41. Lara-Tejero M., Galán J. E. (2000). A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-Like protein. Science 290, 354–357. 10.1126/science.290.5490.354 [DOI] [PubMed] [Google Scholar]
  42. Lee J. H., Park J. H., Cho M. H., Lee J. (2012). Flavone reduces the Production of virulence factors, staphyloxanthin and α-hemolysin, in Staphylococcus aureus. Curr. Microbiol. 65, 726–732. 10.1007/s00284-012-0229-x [DOI] [PubMed] [Google Scholar]
  43. Lin C. D., Lai C. K., Lin Y. H., Hsieh J. T., Sing Y. T., Chang Y. C., et al. (2011). Cholesterol depletion reduces entry of Campylobacter jejuni cytolethal distending toxin and attenuates intoxication of host cells. Infect. Immun. 79, 3563–3575. 10.1128/IAI.05175-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Line J. E. (2001). Development of a selective differential agar for isolation and enumeration of Campylobacter spp. J. Food Prot. 64, 1711–1715. 10.4315/0362-028X-64.11.1711 [DOI] [PubMed] [Google Scholar]
  45. Luangtongkum T., Jeon B., Han J., Plummer P., Logue C. M., Zhang Q. (2009). Antibiotic resistance in Campylobacter: emergence, transmission and persistence. Future Microbiol. 4, 189–200. 10.2217/17460913.4.2.189 [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. McKillip J. L., Jaykus L. A., Drake M. (1998). rRNA stability in heat-killed and UV-irradiated enterotoxigenic Staphylococcus aureus and Escherichia coli O157:H7. Appl. Environ. Microbiol. 64, 4264–4268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Michiels J., Missotten J., Dierick N., Fremaut D., Maene P., Smet S. D. (2008). In vitro degradation and in vivo passage kinetics of carvacrol, thymol, eugenol and trans-cinnamaldehyde along the gastrointestinal tract of piglets. J. Sci. Food Agric. 88, 2371–2381. 10.1002/jsfa.3358 [DOI] [Google Scholar]
  48. Monteville M. R., Konkel M. E. (2002). Fibronectin-facilitated invasion of T84 eukaryotic cells by Campylobacter jejuni occurs preferentially at the basolateral cell surface. Infect. Immun. 70, 6665–6671. 10.1128/IAI.70.12.6665-6671.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Monteville M. R., Yoon J. E., Konkel M. E. (2003). Maximal adherence and invasion of INT 407 cells by Campylobacter jejuni requires the CadF outer-membrane protein and microfilament reorganization. Microbiology 149, 153–165. 10.1099/mic.0.25820-0 [DOI] [PubMed] [Google Scholar]
  50. Nazzaro F., Fratianni F., Coppola R. (2013). Quorum sensing and phytochemicals. Int. J. Mol. Sci. 14, 12607–12619. 10.3390/ijms140612607 [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Newell D. G., Koopmans M., Verhoef L., Duizer E., Aidara-Kane A., Sprong H., et al. (2010). Food-borne diseases - the challenges of 20 years ago still persist while new ones continue to emerge. Int. J. Food Microbiol. 139(Suppl. 1), S3–S15. 10.1016/j.ijfoodmicro.2010.01.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Niu C., Gilbert E. S. (2004). Colorimetric method for identifying plant essential oil components that affect biofilm formation and structure. Appl. Environ. Microbiol. 70, 6951–6956. 10.1128/AEM.70.12.6951-6956.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Oh E., Jeon B. (2015). Synergistic anti-Campylobacter jejuni activity of fluoroquinolone and macrolide antibiotics with phenolic compounds. Front. Microbiol. 6:1129. 10.3389/fmicb.2015.01129 [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Olkkola S., Culebro A., Juntunen P., Hänninen M. L., Rossi M. (2016). Functional genomics in Campylobacter coli identified a novel streptomycin resistance gene located in a hypervariable genomic region. Microbiology 162, 1157–1166. 10.1099/mic.0.000304 [DOI] [PubMed] [Google Scholar]
  55. Payot S., Bolla J. M., Corcoran D., Fanning S., Mégraud F., Zhang Q. (2006). Mechanisms of fluoroquinolone and macrolide resistance in Campylobacter spp. Microbe Infect. 8, 1967–1971. 10.1016/j.micinf.2005.12.032 [DOI] [PubMed] [Google Scholar]
  56. Periti P., Mazzei T., Mini E., Novelli A. (1993). Adverse effects of macrolide antibacterials. Drug Saf. 9, 346–364. 10.2165/00002018-199309050-00004 [DOI] [PubMed] [Google Scholar]
  57. Pickett C. L., Pesci E. C., Cottle D. L., Russell G., Erdem A. N., Zeytin H. (1996). Prevalence of cytolethal distending toxin production in Campylobacter jejuni and relatedness of Campylobacter sp. cdtB gene. Infect. Immun. 64, 2070–2078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Pogacar M., Klancnik A., Bucar F., Langerholc T., Smole Mozina S. (2016). Anti-adhesion activity of thyme (Thymus vulgaris L.) extract, thyme post-distillation waste, and olive (Olea europea L.) leaf extract against Campylobacter jejuni on polystyrene and intestine epithelial cells. J. Sci. Food Agric. 96, 2723–2730. 10.1002/jsfa.7391 [DOI] [PubMed] [Google Scholar]
  59. Reichling J. (2010). Plant-microbe interactions and secondary metabolites with antibacterial, antifungal and antiviral properties, in Annual Plant Reviews Vol. 39 Functions and Biotechnology of Plant Secondary Metabolites, 2nd Edn, 214–347. [Google Scholar]
  60. Schroeder C. L., Narra H. P., Rojas M., Sahni A., Patel J., Khanipov K., et al. (2015). Bacterial small RNAs in the Genus Rickettsia. BMC Genomics 16:1075. 10.1186/s12864-015-2293-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Si W., Gong J., Chanas C., Cui S., Yu H., Caballero C., et al. (2006). In vitro assessment of antimicrobial activity of carvacrol, thymol and cinnamaldehyde towards Salmonella serotype Typhimurium DT104: effects of pig diets and emulsification in hydrocolloids. J. Appl. Microbiol. 101, 1282–1291. 10.1111/j.1365-2672.2006.03045.x [DOI] [PubMed] [Google Scholar]
  62. Silva J., Leite D., Fernandes M., Mena C., Gibbs P. A., Teixeira P., et al. (2011). Campylobacter spp. as a foodborne pathogen: a review. Front. Microbiol. 2:200. 10.3389/fmicb.2011.00200 [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Singh P., Jayaramaiah R. H., Agawane S. B., Vannuruswamy G., Korwar A. M., Anand A., et al. (2016). Potential dual role of eugenol in inhibiting advanced glycation end products in diabetes: proteomic and mechanistic insights. Sci. Rep. 6:18798. 10.1038/srep18798 [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Tasara T., Stephan R. (2007). Evaluation of housekeeping genes in Listeria monocytogenes as potential internal control references for normalizing mRNA expression levels in stress adaptation models using real-time PCR. FEMS Microbiol. Lett. 269, 265–272. 10.1111/j.1574-6968.2007.00633.x [DOI] [PubMed] [Google Scholar]
  65. Thong B. Y., Tan T. C. (2011). Epidemiology and risk factors for drug allergy. Br. J. Clin. Pharmacol. 71, 684–700. 10.1111/j.1365-2125.2010.03774.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Tong F., Gross A. D., Dolan M. C., Coats J. R. (2013). The phenolic monoterpenoid carvacrol inhibits the binding of nicotine to the housefly nicotinic acetylcholine receptor. Pest Manag. Sci. 69, 775–780. 10.1002/ps.3443 [DOI] [PubMed] [Google Scholar]
  67. Tsui W. H., Yim G., Wang H. H., McClure J. E., Surette M. G., Davies J. (2004). Dual effects of MLS antibiotics: transcriptional modulation and interactions on the ribosome. Chem. Biol. 11, 1307–1316. 10.1016/j.chembiol.2004.07.010 [DOI] [PubMed] [Google Scholar]
  68. Upadhyay A., Johny A. K., Amalaradjou M. A., Ananda Baskaran S., Kim K. S., Venkitanarayanan K. (2012). Plant-derived antimicrobials reduce Listeria monocytogenes virulence factors in vitro, and down-regulate expression of virulence genes. Int. J. Food Microbiol. 157, 88–94. 10.1016/j.ijfoodmicro.2012.04.018 [DOI] [PubMed] [Google Scholar]
  69. Upadhyay A., Upadhyaya I., Kollanoor-Johny A., Venkitanarayanan K. (2013). Antibiofilm effect of plant derived antimicrobials on Listeria monocytogenes. Food Microbiol. 36, 79–89. 10.1016/j.fm.2013.04.010 [DOI] [PubMed] [Google Scholar]
  70. van Alphen L. B., Burt S. A., Veenendaal A. K., Bleumink-Pluym N. M., van Putten J. P. (2012). The natural antimicrobial carvacrol inhibits Campylobacter jejuni motility and infection of epithelial cells. PLoS ONE 7:e45343. 10.1371/journal.pone.0045343 [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Xue J., Murrieta C. M., Rule D. C., Miller K. W. (2008). Exogenous or L-rhamnose-derived 1, 2-propanediol is metabolized via a pduD-dependent pathway in Listeria innocua. Appl. Environ. Microbiol. 74, 7073–7079. 10.1128/AEM.01074-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Young K. T., Davis L. M., DiRita V. J. (2007). Campylobacter jejuni: molecular biology and pathogenesis. Nat. Rev. Microbiol. 5, 665–679. 10.1038/nrmicro1718 [DOI] [PubMed] [Google Scholar]

Articles from Frontiers in Microbiology are provided here courtesy of Frontiers Media SA

RESOURCES